Total Payments
$6,128
2024 Payments
$1,243
Companies
45
Transactions
335
Medicare Patients
3,025
Medicare Billing
$596,014
Payment Breakdown by Category
Food & Beverage$6,020 (98.2%)
Education$84.96 (1.4%)
Other$23.52 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,020 | 327 | 98.2% |
| Education | $84.96 | 7 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23.52 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,308 | 99 | $0 (2024) |
| UCB, Inc. | $761.64 | 49 | $0 (2024) |
| Melinta Therapeutics, LLC | $533.46 | 6 | $0 (2024) |
| PFIZER INC. | $333.18 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $236.12 | 14 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $212.69 | 5 | $0 (2024) |
| Neurelis, Inc. | $192.74 | 7 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $187.70 | 12 | $0 (2018) |
| Greenwich Biosciences, Inc. | $178.65 | 3 | $0 (2020) |
| ARGENX US, INC. | $177.97 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,243 | 71 | ABBVIE INC. ($376.35) |
| 2023 | $1,255 | 58 | ABBVIE INC. ($261.85) |
| 2022 | $791.66 | 48 | ABBVIE INC. ($429.45) |
| 2021 | $435.09 | 27 | AbbVie Inc. ($240.21) |
| 2020 | $132.91 | 6 | MERZ NORTH AMERICA, INC. ($33.86) |
| 2019 | $540.48 | 17 | Greenwich Biosciences, Inc. ($150.24) |
| 2018 | $911.17 | 45 | UCB, Inc. ($273.71) |
| 2017 | $818.78 | 63 | UCB, Inc. ($193.26) |
All Payment Transactions
335 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: PAIN | ||||||
| 12/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: PAIN | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: NEUROLOGY | ||||||
| 10/31/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $33.12 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: PAIN | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: PAIN | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: PAIN | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $94.93 | General |
| Category: ANTIBIOTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 929 | 16,641 | $445,279 | $172,597 |
| 2022 | 15 | 724 | 16,797 | $356,821 | $151,889 |
| 2021 | 14 | 643 | 14,650 | $307,714 | $134,607 |
| 2020 | 16 | 729 | 15,910 | $338,863 | $136,920 |
Total Patients
3,025
Total Services
63,998
Medicare Billing
$596,014
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 21 | 15,600 | $140,400 | $73,143 | 52.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 129 | 129 | $67,338 | $19,514 | 29.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 184 | 231 | $45,276 | $16,598 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 132 | $28,607 | $11,680 | 40.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $31,464 | $10,219 | 32.5% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 45 | 45 | $33,336 | $9,601 | 28.8% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 101 | 138 | $19,458 | $6,195 | 31.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 47 | 48 | $20,688 | $6,072 | 29.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 17 | 49 | $21,784 | $5,744 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 87 | $12,592 | $4,835 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 30 | $8,756 | $3,698 | 42.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $8,335 | $3,131 | 37.6% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 11 | 11 | $6,732 | $1,942 | 28.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 27 | $513.00 | $226.80 | 44.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 25 | 16,000 | $144,000 | $76,961 | 53.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 79 | 79 | $41,238 | $11,988 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 135 | $26,055 | $11,552 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 83 | 83 | $25,398 | $9,475 | 37.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 97 | 108 | $21,168 | $7,979 | 37.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 20 | 55 | $21,835 | $6,310 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 43 | $11,223 | $5,871 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 84 | $10,920 | $4,945 | 45.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $10,724 | $4,590 | 42.8% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 61 | 85 | $11,985 | $4,040 | 33.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 22 | 22 | $9,482 | $2,954 | 31.2% |
About Dr. Jonathan Kerrick, MD
Dr. Jonathan Kerrick, MD is a Neurology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871565002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Kerrick, MD has received a total of $6,128 in payments from pharmaceutical and medical device companies, with $1,243 received in 2024. These payments were reported across 335 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,020).
As a Medicare-enrolled provider, Kerrick has provided services to 3,025 Medicare beneficiaries, totaling 63,998 services with total Medicare billing of $596,014. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Gainesville, GA
- Active Since 02/02/2006
- Last Updated 12/02/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1871565002
Products in Payments
- QULIPTA (Drug) $797.33
- Briviact (Drug) $611.45
- NURTEC ODT (Drug) $382.44
- Kimyrsa (Drug) $309.39
- UBRELVY (Drug) $283.24
- BOTOX (Biological) $227.29
- SOLIRIS (Drug) $195.20
- VALTOCO (Drug) $192.74
- Epidiolex (Drug) $178.65
- ONZETRA Xsail (Drug) $154.08
- Orbactiv (Drug) $147.55
- APTIOM (Drug) $144.78
- EMGALITY (Drug) $142.11
- Aimovig (Biological) $138.59
- AIMOVIG (Biological) $136.93
- Nourianz (Drug) $90.71
- VYVGART (Drug) $86.60
- NUPLAZID (Drug) $85.17
- TYSABRI (Biological) $73.12
- RYTARY (Drug) $72.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Gainesville
Dr. Steven Dekosky, Md, MD
Neurology — Payments: $143,382
Neurology $143,382
Dr. Michael Okun, Md, MD
Neurology — Payments: $139,637
Neurology $139,637
Dr. Daniel Cobb, Md, MD
Neurology — Payments: $83,534
Neurology $83,534
James Wymer, Md, MD
Neurology — Payments: $48,627
Neurology $48,627
Dr. Torge Rempe, M.d, M.D
Neurology — Payments: $38,279
Neurology $38,279
Dr. Kathryn Moore, M.d, M.D
Neurology — Payments: $35,290
Neurology $35,290